- This study suggests that RANK ligand inhibitors should be further studied as a breast cancer prevention drug.
- This is early research—it was done using cells grown in the lab and mice. More work needs to be done to confirm these findings in humans.
- While this study involves BRCA1, the results are not ready for use in young women at high risk for breast cancer. Clinical trials are necessary before these drugs can be used in humans.